Quantitative Prediction of Human Hepatic Clearance for P450 and Non-P450 Substrates from In Vivo Monkey Pharmacokinetics Study and In Vitro Metabolic Stability Tests Using Hepatocytes.


Journal

The AAPS journal
ISSN: 1550-7416
Titre abrégé: AAPS J
Pays: United States
ID NLM: 101223209

Informations de publication

Date de publication:
23 01 2019
Historique:
received: 03 07 2018
accepted: 02 01 2019
entrez: 24 1 2019
pubmed: 24 1 2019
medline: 15 2 2020
Statut: epublish

Résumé

Accurate prediction of human pharmacokinetics for drugs remains challenging, especially for non-cytochrome P450 (P450) substrates. Hepatocytes might be suitable for predicting hepatic intrinsic clearance (CL

Identifiants

pubmed: 30673906
doi: 10.1208/s12248-019-0294-1
pii: 10.1208/s12248-019-0294-1
doi:

Substances chimiques

Cytochrome P-450 Enzyme System 9035-51-2
Oxygenases EC 1.13.-
dimethylaniline monooxygenase (N-oxide forming) EC 1.14.13.8
Aldehyde Oxidase EC 1.2.3.1
Glucuronosyltransferase EC 2.4.1.17
Esterases EC 3.1.-

Types de publication

Evaluation Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

20

Références

Nat Rev Drug Discov. 2005 Oct;4(10):825-33
pubmed: 16224454
J Pharm Sci. 1985 Oct;74(10):1097-9
pubmed: 3866061
Drug Metab Dispos. 2009 Jan;37(1):82-9
pubmed: 18832476
Xenobiotica. 1990 Nov;20(11):1201-31
pubmed: 2275215
J Pharm Sci. 2015 Aug;104(8):2627-36
pubmed: 26037784
J Pharm Sci. 2017 Sep;106(9):2678-2687
pubmed: 28238896
J Pharm Pharmacol. 1986 Mar;38(3):177-81
pubmed: 2871151
Br J Clin Pharmacol. 1985 Jan;19(1):79-86
pubmed: 3978023
Clin Pharmacokinet. 1999 Dec;37(6):435-56
pubmed: 10628896
Drug Metab Dispos. 1997 Apr;25(4):524-7
pubmed: 9107553
Drug Metab Dispos. 2012 May;40(5):902-6
pubmed: 22293119
J Pharm Sci. 2010 Aug;99(8):3620-7
pubmed: 20229604
Xenobiotica. 2002 Oct;32(10):835-47
pubmed: 12419014
Drug Metab Dispos. 2010 Aug;38(8):1322-7
pubmed: 20444863
Toxicol Sci. 2001 May;61(1):49-53
pubmed: 11294973
Drug Metab Dispos. 2009 Sep;37(9):1801-5
pubmed: 19541826
Xenobiotica. 2012 Sep;42(9):863-71
pubmed: 22448773
J Pharmacol Exp Ther. 1997 Oct;283(1):46-58
pubmed: 9336307
Nat Rev Drug Discov. 2004 Aug;3(8):711-5
pubmed: 15286737
Clin Pharmacokinet. 1991 Apr;20(4):263-79
pubmed: 2036747
J Med Chem. 2010 Dec 23;53(24):8441-60
pubmed: 20853847
Drug Metab Dispos. 2001 Oct;29(10):1316-24
pubmed: 11560875
Drug Metab Pharmacokinet. 2014;29(2):168-76
pubmed: 24042473
Drug Metab Pharmacokinet. 2012;27(5):466-77
pubmed: 22813719
Drug Metab Dispos. 2007 Nov;35(11):2040-4
pubmed: 17670842
Pharmacogenet Genomics. 2011 Sep;21(9):523-30
pubmed: 21829131
Toxicology. 2000 Apr 3;144(1-3):71-81
pubmed: 10781873
Drug Metab Dispos. 2002 Aug;30(8):892-6
pubmed: 12124306
J Clin Pharmacol. 2009 May;49(5):513-33
pubmed: 19299532
AAPS J. 2009 Jun;11(2):262-76
pubmed: 19408130
Biochem Pharmacol. 1994 Apr 29;47(9):1469-79
pubmed: 8185657
Biochem Pharmacol. 1995 Feb 14;49(4):421-40
pubmed: 7872949
Chem Biol Interact. 1997 Aug 29;106(1):29-45
pubmed: 9305407
Clin Pharmacokinet. 2013 Apr;52(4):225-41
pubmed: 23408070
Drug Metab Dispos. 2000 Dec;28(12):1518-23
pubmed: 11095592
Pharmacol Toxicol. 1998 Apr;82(4):161-6
pubmed: 9584328
Drug Metab Dispos. 2013 May;41(5):1104-11
pubmed: 23444387
Drug Metab Dispos. 2000 May;28(5):560-6
pubmed: 10772635
Drug Metab Dispos. 2005 Jul;33(7):879-83
pubmed: 15821046
Biopharm Drug Dispos. 2010 Jul;31(5-6):286-97
pubmed: 20549836
Drug Metab Dispos. 2004 Nov;32(11):1201-8
pubmed: 15304429
Mol Pharm. 2013 Apr 1;10(4):1262-8
pubmed: 23363487
Drug Metab Dispos. 2010 Feb;38(2):215-22
pubmed: 19875501
Toxicol Pathol. 1996 Jan-Feb;24(1):48-57
pubmed: 8839280
Curr Drug Metab. 2009 Mar;10(3):307-21
pubmed: 19442091
Clin Pharmacokinet. 1999 Mar;36(3):211-31
pubmed: 10223169
Curr Drug Metab. 2008 Nov;9(9):940-51
pubmed: 18991591
Jpn J Pharmacol. 2000 Oct;84(2):213-20
pubmed: 11128045
Drug Metab Dispos. 2003 May;31(5):580-8
pubmed: 12695346
Drug Metab Dispos. 2017 Nov;45(11):1178-1188
pubmed: 28887366
J Clin Psychopharmacol. 2003 Jun;23(3):229-32
pubmed: 12826984
Drug Metab Dispos. 2003 May;31(5):606-11
pubmed: 12695349
Curr Opin Drug Discov Devel. 2001 Jan;4(1):36-44
pubmed: 11727321
Pharmacol Ther. 1997;73(2):147-71
pubmed: 9131722
Annu Rev Pharmacol Toxicol. 1998;38:257-88
pubmed: 9597156
Drug Metab Dispos. 2012 Apr;40(4):825-35
pubmed: 22275465
Pharmacol Ther. 2005 Apr;106(1):97-132
pubmed: 15781124
Drug Metab Rev. 2004 May;36(2):335-61
pubmed: 15237858

Auteurs

Haruka Nishimuta (H)

Preclinical Research Unit, Sumitomo Dainippon Pharma Co., Ltd., 3-1-98 Kasugade-naka, Konohana-ku, Osaka, 554-0022, Japan. haruka-nishimuta@ds-pharma.co.jp.

Takao Watanabe (T)

Preclinical Research Unit, Sumitomo Dainippon Pharma Co., Ltd., 3-1-98 Kasugade-naka, Konohana-ku, Osaka, 554-0022, Japan.

Kiyoko Bando (K)

Preclinical Research Unit, Sumitomo Dainippon Pharma Co., Ltd., 3-1-98 Kasugade-naka, Konohana-ku, Osaka, 554-0022, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH